MedPath

A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS)

Phase 3
Conditions
ennox-Gastaut syndrome
Registration Number
JPRN-jRCT2041200096
Lead Sponsor
YAMAMOTO Hideichiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

male or non-pregnant, non-lactating female, age 2 to 35 years,
- A diagnosis of Lennox-Gastaut syndrome, where seizures that result in drops are not completely controlled by current antiepileptic treatments.
- All of the following 4 criteria for Lennox-Gastaut syndrome
- Onset of seizures at 11 years of age or younger.
- Multiple seizure types (must include TS or TA), including countable motor seizures that result in drops. Countable motor seizure types eligible for inclusion are: GTC, TS, CS, AS, FS with observable motor symptoms, and MS with a drop.
- Abnormal cognitive development.
- Evidence of EEG in the medical history that shows abnormal background activity accompanied by slow spike and wave pattern less than 2.5 Hz.

Exclusion Criteria

-Etiology of seizures is a degenerative neurological disease.
-A history of hemiclonic seizures in the first year of life.
-Drop seizures in clusters, where individual seizures cannot be counted reliably.
-Pulmonary arterial hypertension.
-Current or past history of cardiovascular or cerebrovascular disease, such as cardiac valvulopathy, myocardial infarction or stroke, or clinically significant structural cardiac abnormality, including but not limited to mitral valve prolapse, atrial or ventricular septal defects, patent ductus arteriosis.
-Current or recent history of Anorexia Nervosa, bulimia, or depression within the prior year that required medical treatment or psychological treatment for a duration greater than 1 month.
-A current or past history of glaucoma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath